Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Osteoporosis 2Breast Neoplasms 2Polycystic Ovary Syndrome 1Pituitary Neoplasms 1Myocardial Ischemia 1Infertility, Female 1Heart Diseases 1Fractures, Bone 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Bone Diseases 1

Interventions

Zoledronic Acid 4Denosumab 3Vitamin D 2saracatinib 1radium Ra 223 dichloride 1odanacatib 1etelcalcetide hydrochloride 1cabozantinib 1Standard of Care 1Progestins 1Pamidronate 1Paclitaxel 1Hormone Replacement Therapy 1Exercise 1Estrogens 1Estrogen Replacement Therapy 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium 1Bone Marrow Transplantation 1BHQ880 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Diseases × Hormone Replacement Therapy × Clear all
NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡